Jade Biosciences, Inc. - Common Stock, $0.0001 par value per share (JBIO)

79 filings reported holding JBIO - Jade Biosciences, Inc. - Common Stock, $0.0001 par value per share as of Q3 2025.
Jade Biosciences, Inc. - Common Stock, $0.0001 par value per share (JBIO) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 31.6M shares of 33M outstanding shares and own 95.9% of the company stock.
Largest 10 shareholders include FMR LLC (4.89M shares), Fairmount Funds Management LLC (3.22M shares), VR ADVISER, LLC (3.22M shares), Deep Track Capital, LP (2.28M shares), BlackRock, Inc. (2.15M shares), VANGUARD GROUP INC (1.73M shares), Versant Venture Management, LLC (1.53M shares), RTW INVESTMENTS, LP (1.45M shares), Frazier Life Sciences Management, L.P. (1.41M shares), and Driehaus Capital Management LLC (1.26M shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.